Applied Aerospace & Defense revenue jumps 47% as backlog crosses $1.1bn

Applied Aerospace & Defense, Inc., listed on the New York Stock Exchange as AADX, reported record second-quarter 2026 revenue of $167.3 million as demand improved across space and launch systems, defence aviation, airborne systems, C5ISR and precision strike systems. Revenue rose 47.4% year over year, while adjusted EBITDA increased 38.5% to $36.4 million and contract backlog climbed above $1.1 billion. The results were the company’s first quarterly report after its June 2026 initial public offering, which raised approximately $635.6 million of net primary proceeds and reduced pro forma net leverage to 2.7 times. However, the company also reported a GAAP net loss of $154.0 million, mainly reflecting share-based compensation and IPO-related transaction expenses. With $AADX trading around $19.11 after the release, below its $20 IPO price, investors are weighing strong aerospace and defence demand against the accounting noise, leverage, acquisition integration and manufacturing-scale risks that come with a newly public supplier.

The quarter gives Applied Aerospace & Defense a strong operating narrative but a more complicated stock-market debut story. The company is growing into markets that investors want exposure to, including commercial space launch, satellite production, integrated air and missile defence, radar programmes, precision strike systems, defence aviation sustainment and next-generation airborne systems. Yet the share-price reaction shows that public-market investors are not simply rewarding backlog and revenue growth. They are asking whether the company can convert demand into durable margins, cash flow and cleaner reported earnings.

Why does Applied Aerospace & Defense’s first public quarterly report matter beyond the revenue beat?

The second-quarter report matters because Applied Aerospace & Defense is now being judged as a public company rather than as a private-equity-backed manufacturing platform. Before the IPO, the investment case could be framed around aerospace and defence demand, customer relationships and industrial capacity. After the IPO, the market gets to see the full tension between high growth, heavy acquisition history, leverage, share-based compensation and reported profitability.

Revenue growth of 47.4% is strong in any manufacturing context. Excluding the impact of 2026 acquisitions, revenue still increased by $22.5 million, or 19.8%, which shows that organic demand was also meaningful. That distinction is important because investors are often cautious when newly public companies rely heavily on acquisition-driven growth.

Adjusted EBITDA of $36.4 million represented a 21.8% adjusted EBITDA margin, which indicates that the underlying business can generate attractive operating profitability before IPO-related and other excluded items. However, the margin was below the 23.2% level reported in the prior-year quarter, showing that rapid growth and integration activity can still pressure profitability.

The GAAP result moved in the opposite direction. A net loss of $154.0 million and a loss of $1.04 per share create an unfriendly headline, even when much of the loss reflects share-based compensation and transaction-related items. Public investors often tolerate adjusted earnings during a transition quarter, but they still want a clear path to cleaner reported results.

That is why the stock sold off despite the revenue beat. The company delivered growth, backlog and adjusted EBITDA. The market focused on the IPO hangover, GAAP loss, leverage history and whether the valuation still leaves enough room for execution risk.

How did space, launch systems and defence demand drive Applied Aerospace & Defense’s Q2 growth?

Applied Aerospace & Defense grew across all three core markets in the quarter, but the mix shows why the company is attracting attention inside the defence and space supply chain. Space and Launch Systems revenue rose to $38.8 million from $24.5 million a year earlier, a gain of $14.3 million. That growth was tied to higher launch cadence, satellite production and demand from proliferated constellation programmes.

This is a strategic market because launch vehicles and satellite constellations require complex hardware that can survive extreme thermal, structural and operational conditions. Suppliers that can provide qualified components, advanced materials, composite structures and production capacity become important to both commercial space companies and government space customers.

Defense Aviation and Airborne Systems revenue rose to $78.9 million from $75.3 million. That growth was more modest, but the segment remains Applied Aerospace & Defense’s largest quarterly revenue contributor. Its stability reflects aftermarket demand across a large installed base of aircraft and continued new production activity.

The most dramatic growth came from C5ISR and Precision Strike Systems, where revenue rose to $49.6 million from $13.7 million. That increase of $35.9 million shows how quickly demand is building around integrated air and missile defence, radar systems, national-security electronics and precision strike programmes.

The segment mix matters because it gives Applied Aerospace & Defense three distinct growth engines. Space and Launch Systems offers exposure to launch cadence and satellite production. Defense Aviation and Airborne Systems provides sustainment and platform-linked production. C5ISR and Precision Strike Systems gives the company exposure to missile-defence, radar and munition rearmament priorities.

The risk is that each market has its own operational complexity. Space customers may require fast scale and cost discipline. Defence aviation customers may prioritise qualification and lifecycle support. Precision strike and C5ISR programmes can require security, reliability and programme-specific engineering. Managing all three while integrating acquisitions is not a simple manufacturing exercise.

Why did $AADX fall below its IPO price despite record revenue and backlog growth?

$AADX last traded around $19.11, down about 7.0% from the prior close and below the $20 IPO price set in June. The decline may look counterintuitive because the company beat revenue expectations and reported a larger backlog, but the market reaction reflects the difference between operating momentum and public-company quality of earnings.

The first issue is the GAAP loss. Investors can understand that IPO-related share-based compensation and transaction expenses distort a transition quarter, but a $154.0 million net loss still raises questions. It also makes the company harder to compare with more mature aerospace and defence suppliers that are already reporting cleaner earnings.

The second issue is margin quality. Adjusted EBITDA increased 38.5%, but revenue grew faster at 47.4%. Adjusted EBITDA margin declined year over year to 21.8%. That is still attractive, but it suggests that growth is not yet flowing through with full operating leverage.

The third issue is market anchoring. Because Applied Aerospace & Defense came public at $20 only in June, the IPO price remains a psychological reference point. Falling below that level after the first earnings release creates a perception problem, even if the operating business is improving.

The fourth issue is valuation. A share price near $19.11 and roughly 172.4 million shares outstanding implies a market capitalisation around $3.3 billion. Against full-year 2026 revenue guidance of $670 million to $690 million, the stock still trades at a substantial sales multiple for a manufacturing business.

The market is therefore not saying the business is weak. It is saying the stock still has to prove that rapid growth, backlog conversion and adjusted EBITDA can translate into sustainable earnings and cash generation after the IPO transition fades.

What does the $1.13 billion contract backlog reveal about future revenue visibility?

Applied Aerospace & Defense reported contract backlog of $1.13 billion as of June 30, 2026. That backlog equals approximately 1.66 times the midpoint of full-year 2026 revenue guidance of $680 million, giving the company meaningful multi-year visibility.

Backlog is especially valuable for a manufacturing supplier because it supports planning across labour, facilities, raw materials, supplier commitments and capital investment. Customers in space and defence often need qualified suppliers with capacity already in place, not suppliers that wait for a purchase order before beginning expansion.

The backlog also helps reduce concern that Q2 revenue growth was a one-time spike. A company with strong quarterly growth but weak backlog can quickly disappoint. Applied Aerospace & Defense is showing demand depth across multiple programmes, including enduring platforms and next-generation technologies.

However, backlog is not the same as guaranteed profit. Contract terms, production costs, delivery schedules, inflation, supplier availability and customer-driven changes will determine the quality of that backlog. A large backlog can still disappoint if it converts at weak margins or requires unexpected investment.

The balance between production and aftermarket work will also matter. Aftermarket demand in defence aviation can support steadier margin profiles, while newer space and precision-strike programmes may require more upfront investment, engineering work and capacity ramping.

The company’s backlog gives it a credible runway. The investor question is whether that runway leads to higher cash flow or simply to more working-capital and facility needs.

How do C5ISR and precision strike systems change the company’s defence exposure?

The C5ISR and Precision Strike Systems market was the standout growth category in Q2. Revenue increased to $49.6 million from $13.7 million a year earlier, reflecting higher activity across integrated air and missile defence systems and radar programmes.

This is the most strategically sensitive part of the portfolio because it connects Applied Aerospace & Defense to the defence market’s highest-priority procurement areas. Missile and munition rearmament, layered missile defence, radar modernisation and next-generation precision strike systems are all receiving elevated funding attention.

The market need is clear. The United States and allies are trying to rebuild interceptor stockpiles, increase radar coverage, improve command-and-control networks and develop longer-range precision fires. That creates demand for companies able to produce specialised hardware for harsh operating environments.

Applied Aerospace & Defense does not need to be the prime contractor on a missile or radar programme to benefit. A supplier with qualified manufacturing processes, composite expertise, structural capability and production scale can become embedded inside larger systems sold by primes.

That position can be attractive because it gives exposure to multiple programmes without owning the full platform risk. However, it can also create customer concentration and pricing pressure if major primes push suppliers hard on cost, schedule and quality.

The company’s future in this category will depend on whether it can win more content per programme and scale production without quality escapes. In missile-defence and precision-strike supply chains, a small component problem can become a large programme delay.

What does the IPO change about Applied Aerospace & Defense’s balance sheet and flexibility?

The June IPO was a central part of the quarter. Applied Aerospace & Defense sold approximately 34.2 million primary shares at $20 each, raised $683.0 million in gross proceeds and generated approximately $635.6 million in net primary proceeds after underwriting discounts, commissions and offering expenses.

That transaction materially changed the balance sheet. The company said the IPO reduced pro forma net leverage to 2.7 times and improved financial flexibility. This matters because the business has used acquisitions to expand its capabilities, including purchases tied to advanced composites, deorbit systems and other strategic manufacturing areas.

Lower leverage gives Applied Aerospace & Defense more room to invest in facilities, people, manufacturing equipment and working capital. That flexibility is valuable at a time when customers are asking suppliers to scale faster across launch, space, missile-defence, aircraft and C5ISR markets.

The balance sheet still needs monitoring. The company reported long-term debt of $395.2 million at June 30, down from $627.0 million at the end of 2025, but still material. Interest expense in Q2 was $26.2 million, which remains a significant drag relative to GAAP profitability.

The IPO also increased share count substantially, with common shares outstanding at approximately 172.4 million at June 30, compared with about 129.7 million at year-end 2025. That dilution is part of the cost of strengthening the balance sheet and funding growth.

The company now has more public-market flexibility, but also more scrutiny. The IPO solved part of the capital-structure problem. It did not remove the need to show that the new capital can earn attractive returns.

Why is manufacturing capacity becoming the central competitive advantage in space and defence?

Applied Aerospace & Defense’s investment case rests on a broader industry shift. In space and defence, customer demand is no longer only for engineering talent or prototype capability. Customers increasingly need suppliers that can manufacture complex hardware repeatedly, reliably and at scale.

The company operates 11 purpose-built facilities across six states and more than 1.5 million square feet of production capacity. That footprint is valuable because defence and space customers do not want fragile supply chains for mission-critical systems. They need capacity that can support prototyping, production and sustainment.

This is especially important in commercial space, where launch cadence and proliferated constellations require faster and more repeatable production. It is also important in defence, where missile-defence, radar and precision-strike requirements are moving from low-rate production toward industrial-scale replenishment.

Manufacturing capacity can become a competitive moat if it is paired with qualification, intellectual-property-enabled processes, materials expertise and long customer relationships. A new entrant can lease a building, but it cannot instantly replicate years of process knowledge, customer approvals and programme embedding.

The risk is that manufacturing assets are expensive. Facilities, machinery, quality systems, skilled labour and inventory require capital. If demand slows or programme timing shifts, fixed costs can pressure margins.

The company’s challenge is to keep capacity utilisation high while avoiding overexpansion. Defence and space customers want speed, but investors want returns on capital. Applied Aerospace & Defense must satisfy both.

How should investors evaluate adjusted EBITDA when GAAP losses remain heavy?

Adjusted EBITDA of $36.4 million gives a more favourable view of the company’s underlying operations than the GAAP net loss of $154.0 million. The difference is driven mainly by $110.1 million of share-based compensation expense, $26.2 million of interest expense, $31.5 million of income tax expense, depreciation and amortisation, transaction costs, and integration-related expenses.

There is a reasonable argument for looking past some IPO-related items in a transition quarter. Share-based compensation tied to the IPO and transaction expenses can distort near-term results and may not recur at the same level.

However, investors should not ignore all adjustments automatically. Share-based compensation can be a real cost for shareholders through dilution. Interest expense is a real cash obligation. Integration expenses may recur if the company continues acquiring businesses. Amortisation reflects acquisition history, and acquisitions remain part of the company’s strategic model.

The adjusted EBITDA margin of 21.8% still suggests the operating base is healthy. That is a positive sign. But the public-market test is whether the company can narrow the gap between adjusted performance and reported results over time.

The full-year outlook calls for adjusted EBITDA of $150 million to $155 million on revenue of $670 million to $690 million. That implies an adjusted EBITDA margin around 22.4% to 22.5% at the midpoint, broadly consistent with the Q2 margin level.

The next question is cash conversion. Adjusted EBITDA can support the story, but investors will want evidence that earnings translate into operating cash flow after working capital, capital expenditures, interest and integration needs.

What customer and programme risks could affect Applied Aerospace & Defense after the IPO?

The first risk is customer concentration. Mission-critical aerospace and defence suppliers often depend on a limited number of large customers and programmes. If one launch customer, defence prime or government programme slows, quarterly revenue can be affected.

The second risk is production execution. Complex hardware for space, missile defence and aviation has little tolerance for quality failures. A supplier problem can delay customer programmes, trigger rework and damage margins.

The third risk is acquisition integration. Applied Aerospace & Defense has expanded through acquisitions, and recent deals contributed to Q2 growth. Integration can add capability, but it also creates management complexity, restructuring costs and cultural risk.

The fourth risk is leverage and interest expense. The IPO improved the balance sheet, but the company still carries debt and meaningful interest costs. Higher rates or slower cash generation could limit flexibility.

The fifth risk is working capital. Growing manufacturing businesses often need inventory, contract assets and receivables before cash collection catches up. Applied Aerospace & Defense reported contract assets of $197.7 million at June 30, up from $140.8 million at year-end 2025, which reflects the cash timing demands of growth.

The sixth risk is defence budget timing. The company benefits from rising spending on precision strike, missile defence and C5ISR, but government funding cycles, continuing resolutions and programme delays can still affect order flow.

The seventh risk is valuation. A newly public stock trading near or below its IPO price can remain volatile until investors gain confidence in reporting quality, cash flow and guidance credibility.

What should executives and investors watch after Applied Aerospace & Defense’s Q2 report?

The first signal will be backlog conversion. The $1.13 billion backlog provides revenue visibility, but investors need to see it convert into sales without margin erosion.

The second signal will be adjusted EBITDA margin. Full-year guidance implies margin around the low 20% range. Holding that level while scaling revenue would support confidence in the company’s manufacturing model.

The third signal will be GAAP normalisation. IPO-related costs may fade, but investors will watch whether share-based compensation, transaction expenses, integration costs and interest expense remain heavy.

The fourth signal will be C5ISR and Precision Strike Systems growth. That category delivered the strongest Q2 increase and is most directly connected to defence rearmament and missile-defence demand.

The fifth signal will be organic growth. Excluding 2026 acquisitions, revenue rose 19.8% in Q2. Maintaining strong organic growth will be important because acquisition-led expansion alone will not justify a premium valuation.

The sixth signal will be balance-sheet progress. Net leverage reduction was a major IPO benefit. Further debt reduction, lower interest costs or stronger cash conversion would improve the public-company story.

The seventh signal will be customer expansion. More content on enduring programmes and next-generation systems would strengthen the case that Applied Aerospace & Defense is becoming a strategic manufacturing partner rather than a narrow component supplier.

Applied Aerospace & Defense delivered a strong first report on revenue, backlog and adjusted EBITDA. The market’s negative reaction shows that public investors are demanding a cleaner path from demand to profit. The company has the right end-market exposure. It now has to prove that public-market discipline can match aerospace and defence manufacturing ambition.

Key takeaways on Applied Aerospace & Defense’s Q2 2026 results and $AADX market reaction

• Applied Aerospace & Defense reported Q2 2026 revenue of $167.3 million, up 47.4% year over year.
• Excluding acquisitions completed in 2026, revenue increased by $22.5 million, or 19.8%.
• Adjusted EBITDA rose 38.5% to $36.4 million, with an adjusted EBITDA margin of 21.8%.
• GAAP net loss was $154.0 million, mainly reflecting share-based compensation and IPO-related transaction expenses.
• Contract backlog reached $1.13 billion, equal to about 1.66 times the midpoint of 2026 revenue guidance.
• Full-year 2026 guidance calls for revenue of $670 million to $690 million and adjusted EBITDA of $150 million to $155 million.
• The June IPO raised about $635.6 million of net primary proceeds and reduced pro forma net leverage to 2.7 times.
• Space and Launch Systems grew strongly, while C5ISR and Precision Strike Systems delivered the largest dollar growth.
• $AADX last traded around $19.11, below its $20 IPO price, as investors focused on the GAAP loss and transition costs.
• The key tests are backlog conversion, adjusted EBITDA margin durability, GAAP normalisation, debt reduction, organic growth and disciplined integration of acquisitions.